首页> 外文期刊>Oncogenesis. >miR-100 maintains phenotype of tumor-associated macrophages by targeting mTOR to promote tumor metastasis via Stat5a/IL-1ra pathway in mouse breast cancer
【24h】

miR-100 maintains phenotype of tumor-associated macrophages by targeting mTOR to promote tumor metastasis via Stat5a/IL-1ra pathway in mouse breast cancer

机译:miR-100通过靶向mTOR促进小鼠Stat5a / IL-1ra途径的肿瘤转移,从而维持肿瘤相关巨噬细胞的表型

获取原文
           

摘要

Tumor-associated macrophages (TAMs), the main part of immune cells in tumor microenvironment (TME), play a potent role in promoting tumorigenesis through mechanisms such as stimulating angiogenesis, enhancing tumor migration and suppressing antitumor immunity. MicroRNAs (miRNAs) are considered as crucial regulators in multiple biological processes. The relationship between miRNAs and macrophages function has been extensively reported, but the roles that miRNAs play in regulating TAMs phenotype remain unclear. In this study, we screened highly expressed microRNAs in TAMs, and first identified that miR-100 represented a TAMs-high expression pattern and maintained TAMs phenotype by targeting mTOR signaling pathway. Moreover, miR-100 expression level in TAMs was positively related to IL-1ra secretion, a traditional immune-suppressive cytokine, which was determined to promote tumor cells stemness via stimulating Hedgehog pathway. Mechanism study suggested that mTOR/Stat5a pathway was involved in IL-1ra transcriptional regulation process mediated by miR-100. More importantly, tumor metastasis and invasion capacity were significantly decreased in a 4T1 mouse breast cancer model injected intratumorally with miR-100 antagomir, and combination therapy with cisplatin showed much better benefit. In this study, we confirm that highly expressed miR-100 maintains the phenotype of TAMs and promotes tumor metastasis via enhancing IL-1ra secretion. Interfering miR-100 expression of TAMs in mouse breast cancer model could inhibit TAMs pro-tumor function and reduce tumor metastasis, which suggests that miR-100 could serve as a potential therapy target to remodel tumor microenvironment in breast cancer.
机译:肿瘤相关巨噬细胞(TAMs)是肿瘤微环境(TME)中免疫细胞的主要组成部分,通过刺激血管生成,增强肿瘤迁移和抑制抗肿瘤免疫等机制,在促进肿瘤发生中发挥着重要作用。 MicroRNA(miRNA)被认为是多种生物学过程中的关键调控因子。 miRNA和巨噬细胞功能之间的关系已被广泛报道,但miRNA在调节TAM表型中所起的作用仍不清楚。在这项研究中,我们筛选了TAM中高表达的microRNA,并首先确定了miR-100代表TAM高表达模式并通过靶向mTOR信号通路来维持TAM表型。此外,TAMs中miR-100的表达水平与IL-1ra分泌呈正相关,IL-1ra分泌是一种传统的免疫抑制性细胞因子,被确定通过刺激刺猬通路促进肿瘤细胞的干性。机制研究表明,mTOR / Stat5a通路参与了miR-100介导的IL-1ra转录调控过程。更重要的是,在瘤内注射miR-100 antagomir的4T1小鼠乳腺癌模型中,肿瘤转移和侵袭能力显着降低,并且顺铂联合治疗显示出更好的获益。在这项研究中,我们确认高表达的miR-100可以维持TAM的表型,并通过增强IL-1ra分泌来促进肿瘤转移。干扰小鼠乳腺癌模型中TAM的miR-100表达可以抑制TAMs的促肿瘤功能并减少肿瘤转移,这表明miR-100可以作为重塑乳腺癌微环境的潜在治疗靶点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号